2Yamamoto Y,Maeshima Y, Kitayama H,et al.Tumstatin peptide,an inhibitor of angiogenesis, prevents glomerular hypertrophy in the early stage of diabetic nephropathy[J].Diabetes, 2004,53 : 1831.
4Kang DH ,Kanellis J,Hugo C ,et al.Role of the Microvascular endothelium in progressive renal disease[J].J Am Soc Nephrol,2002,13:806.
5Kang DH ,Johnson ILl.Vascular endothelial growth factor: a new player in the pathogenesis of renal fibrosis[J].Curr Opin Nephrol Hypertens, 2003,12: 43.
6Gamble JR,Drew J,trezise L,et al.angiopoietin-1 is an antipermeability and anti-informmatory agent in vitro and targets cell junctions[J]. Circ Res,2000,87:603.
8Yuan HT, Suri C ,Yancopoulos GD ,et al.Expression of angiopoietin- 1 ,angiopoietin-2 and Tie-2 receptor tyrosine kinase during mouse kidney maturation[J].J Am Soc Nephrol, 1999,10:1722.
9Satchell SC,Anderson KL,Mathieson PW,et al.Angiopoietin 1 and vascular endothelial growth factor modulate human glomerular endothelial cell barrier properties[J].J Am Soc Nephrol,2004,15:566.
10Sugimoto H, Hamano Y, Charytan D, et al.neutralization of circulating vascular endothelial growth factor(VEGF) by anti-VEGF antibodies and soluble VEGF receptor l(sFlt-1) induces proteinuria[J]. J Biol Chem,2003,278 : 12605.
